e-Brochure

PDF version of Drug Design MSc

Contact details

Dr Edith Chan/ Dr Andrei Okorokov

Email: edith.chan@ucl.ac.uk; a.okorokov@ucl.ac.uk

Tel: +44 (0)20 7679 6710/ 0959

Fees and funding

UK/EU 2013/14:

£11,500 (FT)

Overseas 2013/14:

£22,250 (FT)

Full details of funding opportunities can be found on the UCL Scholarships website

More information

Prospectus Entry

Medicine

Key facts

Research Assessment Rating

75% rated 4* (world-leading) or 3* (internationally excellent)
(What is the RAE?)

The programme information on this page relates to 2013 entry. 2014 content to appear here shortly. 

Drug Design MSc

This MSc offers a comprehensive guide to all aspects of drug design. Students will investigate the approaches and methods of modern drug design, particularly how to manage the diversity and wealth of the merging knowledge in this area. The programme will be taught by research scientists and clinicians, and feature a series of lectures by industry experts.

Degree summary

What will I learn?

The programme covers all aspects of drug design, including genomics, bioinformatics, structural biology, cheminformatics, molecular modelling and fragment based drug design, drug target selection, intellectual property and marketing. New therapies and research areas such as antibodies, siRNA, stem cells and high throughput screening are covered. Students will develop essential skills such as research methods and techniques of drug design.

Why should I study this degree at UCL?

UCL (University College London) is rated in the World's top ten universities in the THE-QS 2011 rankings and is located in the centre of one of the world's finest cities. UCL is one of Europe's best and largest centres for biomedical research.

At The Wolfson Institute for Biomedical Research, we have pioneered multi-disciplinary research with a particular emphasis on translating that research into useful clinical benefit. Our research expertise includes: Medicinal chemistry, Computational drug design, Neuronal development and signalling, Cell cycle control, Intensive care medicine, Stem cells, Mitochondrial biology and Cancer.

See subject website for more information:

Degree structure

Availability: Full-time 1 year; Distance Learning is available - flexible study up to three years

Students undertake modules to the value of 180 credits. The programme consists of eight core modules (120 credits) and a research project (60 credits).

A Postgraduate Diploma (120 credits, full-time nine months) is offered.

Core Modules

  • Bioinformatics and Structural Biology
  • Target Identification and High Throughput Screening
  • Cheminformatics and Computer Drug Design
  • Biological Molecules as Therapeutics - Antibodies, siRNA, and Stem Cells
  • Biophysical Screening Methods, Protein NMR and Phenotypic Screening
  • Fragment Based Drug Design (FBDD)
  • Target Selection - Scientific Grounds
  • Target Selection - Commercial and Intellectual Property

Options

  • There are no optional modules for this programme.

Dissertation/report

All MSc students undertake an independent research project which can take the form of a literature project, wet lab/computer modelling based project or an external project with an industrial sponsor.

Teaching and Learning

The programme is delivered through a combination of lectures, tutorials, self study, practical sessions and discussion groups. The research project forms one third of the programme. Each of the taught modules is assessed by unseen written examination (50%) and coursework (50%). The research project is assessed by the dissertation and viva.

Further details available on subject website:

Entry and application

Entry requirements

A minimum of a second-class Bachelor's degree in a relevant subject from a UK university or an overseas qualification of an equivalent standard.

For overseas equivalencies see the relevant country page.

How to apply

You may choose to apply online or download application materials; for details visit www.ucl.ac.uk/gradapps

The deadline for applications is 2 August 2013. Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.

Who can apply?

This MSc is suitable for life science graduates in biological sciences, chemical sciences and pharmacy who wish to obtain a broad understanding of the drug design process, either to establish a career in drug design and related industries, or to pursue further PhD or medical studies in this field.

What are we looking for?

When we assess your application we would like to learn:

  • why you want to study Drug Design at graduate level
  • why you want to study Drug Design at UCL
  • what particularly attracts you to this programme
  • how your academic and professional background meets the demands of this programme
  • where you would like to go professionally with your degree
Together with essential academic requirements, the personal statement is your opportunity to illustrate whether your reasons for applying to this programme match what the programme will deliver.

Career

The programme will provide a good background for students looking to establish a career in drug design/discovery and related industries (Biotech, Pharma, National research labs and NHS agencies), and for industry professionals seeking to gain a greater understanding of new methodology. The knowledge and transferable skills delivered will also be useful for those intending further PhD or medical studies.

Find out more about London graduates' careers by visiting the Careers Group (University of London) website:


Request content update l Request printed information l Disclaimer
Page maintained by Publications and Marketing Services